rs2227861

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001111067.4(ACVR1):​c.270C>T​(p.Ala90Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.75 in 1,613,950 control chromosomes in the GnomAD database, including 465,080 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.64 ( 34999 hom., cov: 31)
Exomes 𝑓: 0.76 ( 430081 hom. )

Consequence

ACVR1
NM_001111067.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.73

Publications

29 publications found
Variant links:
Genes affected
ACVR1 (HGNC:171): (activin A receptor type 1) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
ACVR1 Gene-Disease associations (from GenCC):
  • fibrodysplasia ossificans progressiva
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 2-157780398-G-A is Benign according to our data. Variant chr2-157780398-G-A is described in ClinVar as Benign. ClinVar VariationId is 257464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.73 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.901 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001111067.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACVR1
NM_001111067.4
MANE Select
c.270C>Tp.Ala90Ala
synonymous
Exon 4 of 11NP_001104537.1D3DPA4
ACVR1
NM_001105.5
c.270C>Tp.Ala90Ala
synonymous
Exon 4 of 11NP_001096.1D3DPA4
ACVR1
NM_001347663.1
c.270C>Tp.Ala90Ala
synonymous
Exon 4 of 11NP_001334592.1Q04771

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACVR1
ENST00000434821.7
TSL:1 MANE Select
c.270C>Tp.Ala90Ala
synonymous
Exon 4 of 11ENSP00000405004.1Q04771
ACVR1
ENST00000263640.7
TSL:1
c.270C>Tp.Ala90Ala
synonymous
Exon 4 of 11ENSP00000263640.3Q04771
ACVR1
ENST00000410057.6
TSL:1
c.270C>Tp.Ala90Ala
synonymous
Exon 5 of 12ENSP00000387127.2Q04771

Frequencies

GnomAD3 genomes
AF:
0.638
AC:
96988
AN:
151972
Hom.:
34987
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.271
Gnomad AMI
AF:
0.683
Gnomad AMR
AF:
0.758
Gnomad ASJ
AF:
0.802
Gnomad EAS
AF:
0.923
Gnomad SAS
AF:
0.827
Gnomad FIN
AF:
0.779
Gnomad MID
AF:
0.741
Gnomad NFE
AF:
0.767
Gnomad OTH
AF:
0.664
GnomAD2 exomes
AF:
0.762
AC:
191486
AN:
251244
AF XY:
0.772
show subpopulations
Gnomad AFR exome
AF:
0.256
Gnomad AMR exome
AF:
0.830
Gnomad ASJ exome
AF:
0.806
Gnomad EAS exome
AF:
0.927
Gnomad FIN exome
AF:
0.781
Gnomad NFE exome
AF:
0.762
Gnomad OTH exome
AF:
0.763
GnomAD4 exome
AF:
0.762
AC:
1113826
AN:
1461860
Hom.:
430081
Cov.:
73
AF XY:
0.765
AC XY:
556230
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.242
AC:
8101
AN:
33480
American (AMR)
AF:
0.818
AC:
36594
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.805
AC:
21041
AN:
26136
East Asian (EAS)
AF:
0.918
AC:
36429
AN:
39700
South Asian (SAS)
AF:
0.827
AC:
71298
AN:
86256
European-Finnish (FIN)
AF:
0.783
AC:
41821
AN:
53420
Middle Eastern (MID)
AF:
0.757
AC:
4364
AN:
5768
European-Non Finnish (NFE)
AF:
0.763
AC:
848748
AN:
1111980
Other (OTH)
AF:
0.752
AC:
45430
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
16266
32532
48797
65063
81329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20352
40704
61056
81408
101760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.638
AC:
97018
AN:
152090
Hom.:
34999
Cov.:
31
AF XY:
0.645
AC XY:
47978
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.271
AC:
11228
AN:
41426
American (AMR)
AF:
0.758
AC:
11583
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.802
AC:
2782
AN:
3470
East Asian (EAS)
AF:
0.923
AC:
4777
AN:
5176
South Asian (SAS)
AF:
0.827
AC:
3988
AN:
4822
European-Finnish (FIN)
AF:
0.779
AC:
8250
AN:
10592
Middle Eastern (MID)
AF:
0.748
AC:
220
AN:
294
European-Non Finnish (NFE)
AF:
0.767
AC:
52163
AN:
68004
Other (OTH)
AF:
0.666
AC:
1404
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1419
2839
4258
5678
7097
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.711
Hom.:
20568
Bravo
AF:
0.614
Asia WGS
AF:
0.836
AC:
2907
AN:
3478
EpiCase
AF:
0.765
EpiControl
AF:
0.764

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Progressive myositis ossificans (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
1.1
DANN
Benign
0.71
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227861; hg19: chr2-158636910; COSMIC: COSV99717425; COSMIC: COSV99717425; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.